These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31593490)

  • 21. CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in cell cycle may be a critical process in hepatocellular carcinoma.
    Li L; Huang K; Zhao H; Chen B; Ye Q; Yue J
    Cell Cycle; 2020 May; 19(10):1236-1252. PubMed ID: 32275843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of kinesin family member 4A enhanced cell proliferation via activation of Akt signaling and predicted a poor prognosis in hepatocellular carcinoma.
    Huang Y; Wang H; Lian Y; Wu X; Zhou L; Wang J; Deng M; Huang Y
    Cell Death Dis; 2018 Feb; 9(2):141. PubMed ID: 29396392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Identification of Core Gene Expression Signature in Hepatocellular Carcinoma.
    Li N; Li L; Chen Y
    Oxid Med Cell Longev; 2018; 2018():3478305. PubMed ID: 29977454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
    Li L; Lei Q; Zhang S; Kong L; Qin B
    Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioinformatics analysis of different candidate genes involved in hepatocellular carcinoma induced by HepG2 cells or tumor cells of patients.
    Zhang X; Yin S; Ma K
    J Int Med Res; 2020 Jun; 48(6):300060520932112. PubMed ID: 32567431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
    Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
    World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Based on Integrated Bioinformatics Analysis Identification of Biomarkers in Hepatocellular Carcinoma Patients from Different Regions.
    Teng L; Wang K; Liu Y; Ma Y; Chen W; Bi L
    Biomed Res Int; 2019; 2019():1742341. PubMed ID: 31886176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
    J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Key Biological Processes, Pathways, Networks, and Genes with Potential Prognostic Values in Hepatocellular Carcinoma Using a Bioinformatics Approach.
    Lu H; Zhu Q
    Cancer Biother Radiopharm; 2021 Dec; 36(10):837-849. PubMed ID: 32598174
    [No Abstract]   [Full Text] [Related]  

  • 30. Identification of Potential Gene Network Associated with HCV-Related Hepatocellular Carcinoma Using Microarray Analysis.
    Cheng Y; Ping J; Chen J
    Pathol Oncol Res; 2018 Jul; 24(3):507-514. PubMed ID: 28669080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Biomarkers Based on Bioinformatics Analysis: The Expression of Ubiquitin-Conjugating Enzyme E2T (UBE2T) in the Carcinogenesis and Progression of Hepatocellular Carcinoma.
    Zhao X; Weng W; Jin M; Li S; Chen Q; Li B; Zhou Z; Lan C; Yang Y
    Med Sci Monit; 2021 Mar; 27():e929023. PubMed ID: 33658475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive analysis of a TPX2-related TRHDE-AS1/PKIA ceRNA network involving prognostic signatures in Hepatitis B virus-infected hepatocellular carcinoma.
    Li G; Wang Z; Chen D; Yin J; Mo Z; Sun B; Yang T; Zhang X; Zhai Z; Li Y; Chen P; Dai Y; Wang Z; Ma J
    Front Cell Infect Microbiol; 2022; 12():1025900. PubMed ID: 36204642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanisms of pathogenesis in hepatocellular carcinoma revealed by RNA‑sequencing.
    Liu Y; Yang Z; Du F; Yang Q; Hou J; Yan X; Geng Y; Zhao Y; Wang H
    Mol Med Rep; 2017 Nov; 16(5):6674-6682. PubMed ID: 28901494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.
    Weiler SME; Pinna F; Wolf T; Lutz T; Geldiyev A; Sticht C; Knaub M; Thomann S; Bissinger M; Wan S; Rössler S; Becker D; Gretz N; Lang H; Bergmann F; Ustiyan V; Kalin TV; Singer S; Lee JS; Marquardt JU; Schirmacher P; Kalinichenko VV; Breuhahn K
    Gastroenterology; 2017 Jun; 152(8):2037-2051.e22. PubMed ID: 28249813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Four novel biomarkers for bladder cancer identified by weighted gene coexpression network analysis.
    Yan X; Guo ZX; Liu XP; Feng YJ; Zhao YJ; Liu TZ; Li S
    J Cell Physiol; 2019 Aug; 234(10):19073-19087. PubMed ID: 30927274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and validation of real hub genes in hepatocellular carcinoma based on weighted gene co-expression network analysis.
    Qiao Y; Yuan F; Wang X; Hu J; Mao Y; Zhao Z
    Cancer Biomark; 2022; 35(2):227-243. PubMed ID: 36120772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.
    Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K
    Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated Transcriptomic Analysis Revealed Hub Genes and Pathways Involved in Sorafenib Resistance in Hepatocellular Carcinoma.
    Jiang X; Zhang W; Li L; Xie S
    Pathol Oncol Res; 2021; 27():1609985. PubMed ID: 34737677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrantly DNA Methylated-Differentially Expressed Genes and Pathways in Hepatocellular Carcinoma.
    Cai C; Wang W; Tu Z
    J Cancer; 2019; 10(2):355-366. PubMed ID: 30719129
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.